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Effect of polyunsaturated fatty acids on the growth of murine colon
adenocarcinomas in vitro and in vivo
H.J. Hussey & M.J. Tisdale
Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK.
S_mary }The effect of the polyunsaturated fatty acids (PUFAs) linoleic acid (LA) and arachidonic acid
(AA) on the growth of two murine colon adenocarcinoma cell lines (MAC26 and MAC13) has been
determined both in vitro and in vivo. When the serum concentration in the medium became growth limiting,
low concentrations (18-33 pM) of both PUFAs were growth stimulatory to both cell lines, while higher
concentrations were growth inhibitory. Growth stimulation by AA in both cell lines, and by LA in MAC13,
was effectively inhibited by both the cyclo-oxygenase and lipoxygenase inhibitor indomethacin, and the
lipoxygenase inhibitor BWA4C in a dose-dependent manner. The most effective inhibition was exerted by
BWA4C, suggesting metabolism of both PUFAs through the lipoxygenase pathway for growth stimulation. In
vivo studies using the MAC26 tumour showed a significant stimulation of tumour growth when LA was
administered orally at concentrations higher than 0.4 g kg day- 1 Higher concentrations did not produce a
further increase in tumour growth rate. This suggests that there is a threshold dose for growth stimulation by
LA which, together with that in the diet, amounted to 3.8% of the total caloric intake. The increase in tumour
volume induced by LA arose from a reduction in the potential doubling time from 41 to 28 h and was
effectively reversed by indomethacin (5 mg kg-1). These results suggest that PUFAs may play an important
role in tumour growth and may offer a potential target for the development of chemotherapeutic agents.
Although animal studies have suggested that dietary fat is an
important factor in the aetiology of cancer at a number of
sites, experimental studies in the human population are
limited. The promotional role of long-chain polyunsaturated
fatty acids (PUFAs), particularly linoleic acid (LA), has been
demonstrated in animal models of colon (Reddy & Masura,
1984), breast (Rogers & Wetsel, 1981) and pancreatic cancer
(Roebuck et al., 1985) induced by chemical carcinogens. In
addition cis, cis-linoleic acid has been shown to promote the
growth of transplantable mouse and rat mammary car-
cinomas (Hillyard & Abraham, 1979), suggesting that diet
may be an important factor in tumour progression for
patients with pre-existing cancer.
Although there are no definitive data to support the role of
PUFAs in human cancer, there are alterations of the tumour
and plasma concentration of some n-6 PUFAs which support
this hypothesis. Thus a significant reduction in the concentra-
tion of arachidonic (AA) is observed in malignant prostatic
tissue compared with benign (Chaudry et al., 1991) and may
be due to an increased metabolism. Lower levels of LA as a
percentage of total fatty acids have also been observed in
plasma phospholipids and cholesterol esters and in red blood
cell phospholipids in cancer patients with weight loss (Mos-
coni et al., 1989). In contrast, the AA concentration was
found to be increased in human colorectal cancer compared
with the unaffected mucosa (Neoptolemos et al., 1991). The
basis for the change was not established, but may be due to
increased formation or decreased utilisation.
In order to evaluate more fully the role of PUFA in
tumour cell growth we have utilised the mouse colon
adenocarcinomas, MAC13 and MAC26, as a model system
since both in vitro and in vivo tumours are available. In
contrast to MAC13, MAC26 is a slow-growing tumour, the
growth of which may be limited by availability of fatty
acids.
Materials and meds
Animals
Pure-strain NMRI mice were obtained from our own
breeding colony and were fed a rat and mouse breeding diet
(Pilsbury, Birmingham, UK) and water ad libitum. Male
animals (average body weight 23-26 g) were transplanted
with fragments of the MAC26 tumour into the flank by
means of a trocar and fed the normal diet ad libitum. At 12
days after transplantation when the tumours became pal-
pable animals were randomised into groups to receive LA
dissolved in arachis oil (0.1 ml) daily by gavage. Tumour
dimensions were measured daily by means of calipers and the
volume was calculated from the formula:
Length x (width)2
2
The doubling times of the tumours were determined during
logarithmic growth from daily changes in volume.
Chemicals
['"1J5-Iodo-2'-deoxyuridine (sp. act. 2,000 Ci mmol- ) and
[methyl-3Hlthymidine (sp. act. 5 Ci mmol-') were purchased
from Amersham International (Amersham, UK). LA (99%)
and AA (99%) were purchased as the free acids from Sigma
(Poole, UK). RPMI-1640 tissue culture medium and fetal
calf serum were purchased from Gibco (Paisley, UK). Fatty
acids were complexed to sterile bovine serum albumin (fatty
acid free) in water on an equal weight basis. The acid was
neutralised with equimolar sodium bicarbonate and sonicated
for 5 min to form micelles. Indomethacin was purchased
from Sigma (Dorset, UK). BWA4C was kindly donated by
L. Garland, Wellcome Research Laboratories, Kent, UK.
The fatty acid composition of the rat and mouse breeding
diet and arachis oil was determined by gas-liquid chromato-
graphic (GIC) analysis of the fatty acids as the methyl esters
as previously described (Hudson et al., 1993) and is given in
Table I.
Cell culture
The MAC13 and MAC26 mouse colon adenocarcinoma cell
lines were derived from the solid tumours and kindly donated
by J. Double, University of Bradford, Bradford, UK. They
were maintained in RPMI-1640 medium containing 10%
fetal calf serum under an atmosphere of 5% carbon dioxide
in air and were passaged twice a week. Cells for growth
experiments were taken from logarithmically growing cul-
tures and seeded at an initial cell density of 2 x 104 ml ' and
cell counts were determined daily by means of a Coulter
Electronic Particle Counter, model D.
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Table I Fatty acid composition of rat and mouse breeding diet
(RMB) and arachis oil
Per cent of total PUFA
Fattu acid RMB Arachis oil
16:0 13.5 2
18:0 2.6 10
18:1 (n=9) 24.3 50
18:2 (n = 6) 55.1 25
18:3 (n =6) 4.5
In vivo cell cycle kinetics
The protocol used to measure the kinetics of in vivo growth
stimulation by LA was similar to that described previously
(Gabor et al., 1985; Gabor & Abraham, 1986). Mice bearing
the MAC26 tumour were randomised into two groups of 25
and received either solvent or LA (50 mg day-'). The initial
tumour volumes (control 144 ± 12 mm3 and LA 129 ±
22 mm3) were not significantly different. The mice were given
drinking water containing 0.1% potassium iodide, and on
day 3 each mouse was given an i.p. injection of 20yCi of
['VI]iododeoxyuridine in 0.1 ml of sterile saline. Four animals
from each group were killed 4 h later, and then at 24 h
intervals for a further 4 days. To determine the radioactivity
in tumour cell DNA, the tumours were minced into pieces
1-2 mm3, fixed in a solution ofethanol-acetic acid (3:1, v v)
and washed three times with 2 ml of the same solution over
the next 72 h. This washing procedure was effective in remov-
ing all of the acid-soluble material from the tissues. Radioac-
tivity in the tumour pieces was determined using a Packard
Tri-Carb scintillation spectrometer. The values for c.p.m. per
gram of tumour were plotted on semilogarithmic graph
paper, and the t1 of the decline in specific activity was
determined.
Autoradiographic analysis oftumour sections
Mice bearing the MAC26 tumour were randomised 10 days
after transplantation to receive either solvent or LA
(50 mgday-') for a further 8 day period, when a significant
difference in tumour volumes between the groups was estab-
lished. Both groups were then given 50liCi of [methyl-
3Hlthymidine by i.p. injection, and 4 h and 24 h later three
mice from each group were killed and the tumours excised
and fixed in Bouin's fluid. After 24 h the tumours were
transferred to 70% alcohol and fixed for I week. They were
then wax embedded and sections were cut at 3pm, dipped in
NTB3 (Kodak, New Haven, CT, USA) high-sensitivity auto-
radiography emulsion, which records all charged particles,
and left in lightproof boxes for 3 weeks prior to development
with D19 Kodak developer and fixer.
Results
Growth of two murine colon adenocarcinoma cell lines,
MAC13 and MAC26, was enhanced by both LA and AA
when the serum concentration of the medium was reduced to
2.5% or lower (Figure 1). Control growth of MAC26 cells in
1% serum and MAC13 cells in 0.5% serum was static. Ofthe
concentrations tested, the optimum concentration of LA for
growth stimulation of both cell lines was 18;1M (Figure 2),
while for AA the optimum concentration was 17gLM for
MAC13 and for MAC26 33ILM. The doubling time for
MAC26 cells in medium containing 10% serum was 25 h,
and this was increased to 90 h when the serum concentration
was reduced to 2.5%. However, in medium containing 1%
fetal calf serum plus 18gM LA the doubling time was
reduced to 44 h. Higher concentrations of fatty acid caused
growth inhibition of both cell lines. When the serum concen-
tration in the medium was 1%, stimulation of growth of the
MAC26 line by 18 1M LA was approximately twice that of
the MAC13 cell line, while the maximum extent of growth
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Fugwe 1 Effect of the concentration of serum in the culture
medium on the growth of MAC26 cells in the presence of LA (a)
and AA (b). Cells were seeded at a concentration of 2 x 104ml-'
in medium containing either 2.5 (x) or 1% fetal calf serum (0)
and cell growth was monitored. Results are given as means
± s.e.m. for cell numbers 144 h after seeding and are expressed
relative to the growth of cells in the absence of PUFAs.
Differences are expressed as P<0.05, 'P<0.01 determined by
Student's t-test.
stimulation by AA was approximately the same for both cell
lines. Concentrations of LA between 0.2 and 18gM produced
significant stimulation of the growth of the MAC26 cell line
in medium containing 10% fetal calf serum (Figure 3a), while
AA only produced growth inhibition at concentrations
greater than 33;M (Figure 3b).
To investigate the potential role of metabolites of LA and
AA in the growth-promoting effect, the action of the cyclo-
oxygenase and lipoxygenase inhibitor indomethacin and the
5-lipoxygenase inhibitor BWA4C (Tateson et al., 1988) on
PUFA-stimulated cell growth was determined. For the
MAC26 cell line growth stimulation by either 10% fetal calf
serum or 33i1M AA in medium containing 1% fetal calf
serum was inhibited by both agents in a dose-dependent
manner at concentrations above 10iLM. However, for
BWA4C concentrations below 10pM were synergistic with
AA in stimulating growth of the MAC26 cell line (Figure 4).
The IC5o values for indomethacin (32 ± 8 and 43 ± 15 ELM)
and BWA4C (2 ± 1 and 10 ± 2gM) were similar for stimula-
tion by calf serum and AA, while growth stimulation by
18gtM LA seemed much more resistant to inhibition by either
agent (IC54 80± 21 and 22± 6) respectively). For the
MAC13 cell line, growth stimulation by LA in medium
containing 0.5% fetal calf serum was inhibited by both
indomethacin and BWA4C. The IC50 values for growth
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inhibition in media containine 100o fetal calf serum and in
media containin2 0.5%o fetal calf serum plus AA (33 pm or
LA (18 ISm were similar for both indomethacin (45 1O.
`0 12 and 40 6 JI respectively) and BWN'A4C (4
- 1.
- 1 and 6-1 it respectivelx v. The more effective inhibi-
tion of grow-th bv BWN.A4C sugzests that both LA and AA
stimulate cellular proliferation through a lipoxygenase rather
than a cyclo-oxx genase pathxway. Grow-th stimulation of
MAC26 bv LA appears to be through a pathwaxy that is;
insensitiVe to inhibition bv either agent.
To determine the relex-ance of the in itro studies to
tumour arow-th stimulation bv PUFAs. the effect of LA
dissolved in arachis oil on the groxwth of the NMAC26 tumour
xwas determined inl viio. The expenrment was initiated 12 dax-s
after tumour transplantation wvhen the tumour became pal-
pable (average tumour x-olume 128 14 mm-( and the LA
xxas administered dailv b- gavage. There w-as no significant
difference betxveen the dailv food consumption of control
4.95 12 I and LA (4.6
- 08 gl groups. Arachis oil alone
did not have a significant effect on tumour growxth. Howxever.
dailv administration of LA at a level of 0.4 a ke- caused a
significant increase in tumour xolume (Figure 5. Higher
levels of LA 1 and 2 gLy dailv( also increased tumour
crowxth. but there xwas no difference between the various dose
levels. Doses belovx- (.4 kg (0.2 and 0.04 gy kg- did not
Nigniricantl1 increase tumour croxvth rate. Thiv Suggests that
there is a threshold dose level for tumour arox-th stimulation
bx- LA.
The kinetics of aroxvth stimulation of the MAC26 tumour
in mice b! LA has been determined bx the [- A]-iodo-2
deoxx-uridine method. The relationship betwxeen cell loss (cp(.
the tumour potential doubling time and the tumour
doubling time !a gixen bv the formula:
=P l-r[ ID)
as descn'bed b\ Steel (19-- Values of t, hax-e been sub-
stituted for rt in the formula (Begg. 19--). The results pres-
ented in Table II shox- that the cell loss 1p1 in this tumour
68 O i substantiall1 higher than in the NIAC 16 tumour
(3S°o0 (Hudson e& a!.. 1993'. In addition. the increase in
tumour size induced by L.A appears to arise solely from a
reduction in the potential doubling time from 41 to 28 h
xxithout a change in the cell loss factor. Autoradiography
studies confirmed uniform labelling throughout the tumour
in both control and LA-treated groups.
Indomethacin (5 mg kg- effectixelx abolished the growxth
stimulation of the M.AC26 tumour bv LA in x-ii-o (Figure 6(.
The increase in tumour x-olume in indomethacin-treated mice
was siginificantl1 belowx that found in non-stimulated controls
S and 9 davs after the initiation of the experiment. The
increase in tumour volume in animals receixing indomethacin
xwithout LA did not differ from those not receiving
indomethacin
Discussion
There are noxv considerable data to support a role for lipids
in signal transduction pathx-ax.s Merrill t'l. l989(.
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Fugwe 4 Effect of increasing concentration of indomethacin (a)
and BWA4C (b) on growth of MAC26 cls in medium contain-
ing 10% fetal calf serum (x) or inmedium containing 1% fetal
calf serum and supplemented with 18 504 LA (0) or 33gm AA
(D). Cells wer seeded at a concentration of2 x I0'ml- I and left
3 h before addition ofthe PUFAs. Drug addition was made after
a fther I h and the inhibition results refer to a time period of
144 h after seeding. Figures are expressed as means ± s.e.m. for
three determinations in triplicate.
Tumour growth in vivo has been suggested as being limited
by the availability of substances relased from host fat stores
during lipolysis and in particular to the PUFAs, LA and AA
(Sauer & Dauchy, 1988). While some in vitro studies suggest
that LA and AA are directly cytotoxic to human cancer cells
(Begin et al., 1986), others (Rose & Connolly, 1990) suggest
growth stimulation by LA when the serum concentration of
the medium is reduced or eliminated.
In the present studies both LA and AA were found to
stimulate the growth of two murine colon adenocarcinoma
cell lines, MAC26 and MAC13, in serum-depleted medium in
vitro. The fatty acids were complexed with equal weights of
bovine serum albumin, neutralised with sodium bicarbonate
and sonicated for 5 min before addition to cells. This concen-
tration of albumin was used to overcome problems associ-
ated with growth stimulation by albumin alone at the low
concentration of serum. This process circumvents solubility
problems, although the fatty acid-albumin ratio is much
higher than found in vivo. The optimal concentration of both
LA and AA required for growth stimulation in vitro lay
between 18 and 33jM, and higher concentrations were
growth inhibitory. Thus, these PUFAs appear to have a dual
effect on tumour cell growth in vitro. The growth inhibition
observed at higher concentrations is probably explained by
the toxicity of free fatty acids (cell membrane modification
and disruption, uncoupling of oxidative phosphorylation).
*
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Fugwe 5 Effect of LA dissolved in arachis oil in the growth of
the MAC26 tumour in mak NMRI mic. Animals were ran-
domised on day 1 to receive either arachis oil alone (x) or LA
administered daily by gavage at a dose level of 0.4 (U), I (-) or
2 gkg-' (0). Results are expressed as means ± s.e.m. for ten
mice per treatment group. Differences between controls and LA-
treated groups were determined by two-way ANOVA followed by
Tuckey's test and are: 'P<0.01; 'P<0.05.
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Fugwe 6 Effect of daily i.p. injection of indomethacin
(5 mg kg-'; in 0.1 ml of 10% ethanol) on growth stimulation of
the MAC26 tumour by LA (1 gkg-'). Control animals received
arachis oil alone (x), while the other two groups received either
LA (0) or LA and indomethacin (0). Results are expressed as
means ± s.e.m. for nine mice per treatment group. Differences
were determined by two-way ANOVA followed by Tuckey's test
and are: FP<0.01 from arachis oil group, -P<0.01 from LA-
treated group.
Table II Kinetic parameters of the MAC26 tumour in mice fed
either a normal diet (A) or with supplemental LA (2g kg-') (B)
Group tD (h) t, (h) p (%)
A 130 42 68
B 84 28 67
Previous studies (Buckman et al., 1991) using a murine
mammary carcinoma cell line have attributed the growth-
stimulatory effect of LA in vitro to metabolites from the
lipoxygenase pathway rather than the cyclo-oxygenase path-
way. Hydroxy fatty acid metabolites of LA and AA appear
to be an important element in the epidermal growth factor
(EGF)-regulated cascade of biochemical events leading to
fibroblast mitogenesis (Glasgow & Eling, 1990), and
lipoxygenase-derived metabolites of LA synergise with
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insulin, EGF and prostaglandin E2 in stimulating the growth
of mammary epithelial cells (Bandyopadhyay et al., 1988). In
the present study growth stimulation of both MAC26 and
MAC13 by AA and MAC13 by LA was more effectively
inhibited by the 5-lipoxygenase inhibitor BWA4C than the
cyclo-oxygenase inhibitor indomethacin, suggesting that
metabolism through the lipoxygenase pathway may be more
important in growth stimulation. Growth stimulation of the
MAC26 cell line by LA was not effectively inhibited by either
agent, suggesting that either the intact molecule or other
pathways of metabolism may be important.
In vivo studies, while confirming the ability of LA to
stimulate tumour growth, show no evidence for growth
inhibition as observed in vitro and also suggest a threshold
dose level for tumour growth stimulation at 0.4 g of pure LA
per kg per day. The in vivo studies used pure LA rather than
corn oil to circumvent any problems that may arise in the
interpretation of the results owing to the addition of extra
calories. The concentration ofthe individual fatty acids in the
food was determined by GLC analysis of the methyl esters of
the fatty acids. This showed that the daily consumption of
LA by the mice was 35 mg. It therefore appears that maxi-
mum stimulation of tumour growth occurs when the mice
consume 45 mgday-' LA day, which is equivalent to 3.8%
of the caloric intake. This figure is close to the threshold level
of PUFAs (4% of total energy) (Ip et al., 1985) required for
mammary tumour promotion in vivo. Since this value is
lower than the recommended (Report ofthe British Nutrition
Foundation's Task Force, 1992) human intake (6%), human
tumour growth may be already maxvimally stimulated by
dietary consumption of LA.
The kinetics of growth stimulation of the MAC26 tumour
by LA suggests that the increase in tumour volume results
from an increase in the cell production rate. This conclusion
differs from that of Gabor et al. (1985), who supposed that
stimulation of the growth of a mammary adenocarcinoma in
mice by a diet containing 10% corn oil was the result of a
reduction in the cell loss parameter. These results suggest
that there may be more than one mechanism for stimulation
of tumour growth by LA.
Growth stimulation of the MAC26 tumour by LA in vivo
was effectively abolished by indomethacin. This suggests the
possible involvement of cyclo-oxygenase metabolites. How-
ever, since indomethacin is also capable of inhibiting the
lipoxygenase pathway, the effect of other inhibitors must be
evaluated before the precise metabolic pathway can be de-
lineated. Another inhibitor of the cyclo-oxygenase pathway,
piroxicam, has also shown inhibition of colon carcinogenesis
(Reddy et al., 1987), although again this is complicated by
the fact that this is also an inhibitor of ornithine decarboxy-
lase.
This work has been supported by a grant from the World Cancer
Research Fund.
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